The Effect of Ginger on the Incidence of Postoperative Nausea and Vomiting
NCT ID: NCT03626441
Last Updated: 2018-08-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
110 participants
INTERVENTIONAL
2017-12-02
2018-06-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Ginger on Intraoperative and Postoperative Nausea and Vomiting in Elective Cesarean Section Patients
NCT01733212
Ginger to Prevent Nausea and Vomiting After Laparoscopic Cholecystectomy
NCT07190495
Reducing Up-set Stomach and Vomiting After Surgery Using Essential Oils
NCT03370328
Efficacy of Ginger in the Prevention of Abdominal Distention in Post Cesarean Section Patient
NCT02809027
The Effect of Glycyrrhizin on the Occurrence of Postoperative Nausea and Vomiting
NCT04742660
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Ginger is a cheap, widely available and safe natural product in Jamaica and has been found to reduce the incidence of Nausea and vomiting in other clinical situations, such as in pregnancy. It is believed to act via the inhibition of serotonergic receptors.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo
Two coloured capsules containing 0.5 mg of cornstarch and flavoured with non-active essence of ginger, given 2 hours before the scheduled start of surgery.
Placebo
Two coloured capsules containing 0.5 mg of cornstarch and flavoured with non-active essence of ginger.
Ginger
Two coloured capsules containing 0.5g ginger powder, flavoured with non-active essence of ginger, given 2 hours before the scheduled start of surgery.
Ginger
Capsules containing 0.5g ginger powder, flavoured with non-active essence of ginger
Placebo
Two coloured capsules containing 0.5 mg of cornstarch and flavoured with non-active essence of ginger.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ginger
Capsules containing 0.5g ginger powder, flavoured with non-active essence of ginger
Placebo
Two coloured capsules containing 0.5 mg of cornstarch and flavoured with non-active essence of ginger.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Undergoing elective intra-abdominal, gynaecological surgery
Exclusion Criteria
* Gastroesophageal reflux disease (GERD)
* Allergy to any of the Anaesthesia Agents
* Inability to swallow capsules.
* psychiatric illness which prevents patients giving informed consent.
* Psychological which prevents patients giving informed consent.
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The University of The West Indies
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Patrick J Toppin
Associate lecturer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hyacinth Harding, DM
Role: PRINCIPAL_INVESTIGATOR
UWI, Faculty of medical sciencces
Andrea Myers, MD
Role: STUDY_DIRECTOR
UWI, Faculty of medical sciencces
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of the West Indies
Kingston, Kng 7, Jamaica
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Anaesthesia20182
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.